Get a naturally refreshed and youthful look with
BOTOX® & Xeomin®
Doctors have been using BOTOX® Cosmetic for years to successfully treat wrinkles and facial creases.
Want to look refreshed?
Are you ready to get back to owning your look with fewer lines?
You can… with BOTOX® Cosmetic.
Wellspring Esthetics offers the brand that both medical providers and patients know and trust! Botox Cosmetic is the #1 selling treatment of its kind.
- Quick treatments
- Minimal downtime
- Look like you….only better!
What Does BOTOX® Cosmetic Help With?
BOTOX® Cosmetic injections are frequently used to minimize and diminish wrinkles and lines in the following areas:
- Frown lines between the eyebrows
- Neck wrinkles and bands
- Crow’s feet around the eyes
- Lines on the upper lip
- Downturned corners of the mouth
- Horizontal forehead creases
Did you know that BOTOX can be use as an effective treatment for TMJ (temporo-mandibular joint) disorders and jaw tension?
BOTOX can also be used as an effective treatment for Migraines and chronic headache. Contact us for a consultation for more information.
How Does BOTOX® Cosmetic Work?
BOTOX® Cosmetic blocks signals from the nerves to the muscles, so that the injected muscle temporarily cannot contract… which makes the wrinkles relax and soften.
BOTOX® Cosmetic is most often used on forehead lines, crow’s feet (lines around the eye), and frown lines. Wrinkles caused by sun damage and gravity will not respond to Botox. It can also be used for lip lines and for the chin and corner of the mouth and neck.
How Long Does a BOTOX® Cosmetic Injection Last?
The effects of BOTOX® Cosmetic will last 3-4 months. As muscle action gradually returns, the lines and wrinkles begin to reappear and need to be treated again. The lines and wrinkles often appear less severe with time because the muscles are being trained to relax.
How Is a BOTOX® Cosmetic Procedure Done?
Getting BOTOX® Cosmetic takes only a few minutes and the areas can be numbed with topical anesthesia beforehand if you choose.
BOTOX® Cosmetic is injected with a fine needle into specific muscles with only minor discomfort. It generally takes three to seven days to start seeing effects and you can expect to see full effects at fourteen days. Treatments typically last for 3-4 months depending on the patient.
It is best to avoid alcohol and aspirin and anti-inflammatory medications five days before treatment to reduce bruising.
BOTOX® Treatment for Jaw Tension and TMJ
BOTOX® is used as an alternative treatment for TMJ (temporo-mandibular joint) disorders and associated jaw tension and pain. When injected into facial muscles afflicted with soreness and discomfort, BOTOX® relieves TMJ and jaw tension for many patients. The injections often eliminate headaches resulting from teeth grinding, and, in cases of severe stress, BOTOX® can even minimize lock jaw. Although BOTOX® treatment for these conditions is presently experimental; evidence indicates that it can be extremely effective.
How Does BOTOX® Treat Jaw Tension and TMJ Disorder?
Located on both sides of the head at the point where the jawbone meets the skull, the temporo-mandibular joint (TMJ) is used during talking, eating, swallowing, and other everyday activities. If this joint becomes displaced or is overworked through excessive teeth grinding, a person may suffer severe tension headaches, as well as sharp pain in the jaw. BOTOX® relieves jaw tension by making muscles unable to engage in the powerful, often unconscious movement of the jaw that produces headaches and pain.
The BOTOX® alternative treatment for TMJ disorders and jaw tension is usually quick, straightforward, and effective. A non-surgical procedure, BOTOX® injections are administered in a doctor’s office and treatment requires no hospital stay. Most patients experience noticeable improvement within one or two days of their first treatment, although relief can take up to a week.
Now available at Wellspring Esthetics!
Xeomin® (incobotulinumtoxinA), is a FDA-approved drug, effective in treating the glabellar lines, or the 11 between your eyes. Xeomin works similarly to Botox and Dysport, which relaxes the underlying nerves to smooth out the facial expression lines caused by muscle contraction. Xeomin is injected into the muscles that cause these lines and wrinkles, disabling them and reducing their further deepening.
What’s the difference between Xeomin® and Botox®?
Xeomin and Botox have the same active ingredients, Botulinum neurotoxin. The difference is that Xeomin does not carry the binding proteins that are typical of the other products.
What are the common benefits of Xeomin?
Xeomin reduces wrinkles produced by facial movement, resulting in a younger-looking appearance. Xeomin is especially effective for treating crow’s feet, forehead wrinkles, bunny lines on the nose, and downturned corners of the mouth.
Since Xeomin does not contain protein, it claims that its advantage lies in the lessened likelihood of antibodies being formed to the proteins which – for a very limited number of patients – can render the product ineffective. (This typically is only seen in patients who have used botulinum toxin for an extended period of time.)
What areas can be treated with Xeomin®?
Xeomin® is used to treat dynamic facial wrinkles. Areas most commonly treated by Xeomin® include crow’s feet (lines around the eyes), worry lines between the eyebrows, and the lines across the forehead.
How does Xeomin® work?
Xeomin® works by weakening the muscles of facial expression that insert onto the surface of the skin. Weakening the pull of these muscles on the skin causes the visible wrinkles to flatten out. Over time, cumulative benefits are observed as the skin remodels without the negative influence of the wrinkle-creating facial muscles.
Make your appointment today
Our highly trained, experienced staff place individual patient care and service above all else.
Cosmetic (onabotulinumtoxinA) Important Information
BOTOX® Cosmetic (onabotulinumtoxinA) is indicated in adult patients for the temporary improvement in the appearance of:
– Moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity
– Moderate to severe lateral canthal lines associated with orbicularis oculi activity
– Moderate to severe forehead lines associated with frontalis activity
IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING
WARNING: DISTANT SPREAD OF TOXIN EFFECT
Postmarketing reports indicate that the effects of BOTOX® Cosmetic and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity, but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have an underlying condition that would predispose them to these symptoms. In unapproved uses and approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and spasticity and at lower doses.
BOTOX® Cosmetic is contraindicated in the presence of infection at the proposed injection site(s) and in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation.
WARNINGS AND PRECAUTIONS
Lack of Interchangeability Between Botulinum Toxin Products
The potency units of BOTOX® Cosmetic are specific to the preparation and assay method utilized. They are not interchangeable with other preparations of botulinum toxin products and, therefore, units of biological activity of BOTOX® Cosmetic cannot be compared to nor converted into units of any other botulinum toxin products assessed with any other specific assay method.
Spread of Toxin Effect
Please refer to Boxed Warning for Distant Spread of Toxin Effect.
No definitive serious adverse event reports of distant spread of toxin effect associated with dermatologic use of BOTOX® Cosmetic at the labeled dose of 20 Units (for glabellar lines), 24 Units (for lateral canthal lines), 40 Units (for forehead lines with glabellar lines), 44 Units (for simultaneous treatment of lateral canthal lines and glabellar lines), and 64 Units (for simultaneous treatment of lateral canthal lines, glabellar lines, and forehead lines) have been reported. Patients or caregivers should be advised to seek immediate medical care if swallowing, speech, or respiratory disorders occur.
Serious Adverse Reactions With Unapproved Use
Serious adverse reactions, including excessive weakness, dysphagia, and aspiration pneumonia, with some adverse reactions associated with fatal outcomes, have been reported in patients who received BOTOX® injections for unapproved uses. In these cases, the adverse reactions were not necessarily related to distant spread of toxin, but may have resulted from the administration of BOTOX® to the site of injection and/or adjacent structures. In several of the cases, patients had pre-existing dysphagia or other significant disabilities. There is insufficient information to identify factors associated with an increased risk for adverse reactions associated with the unapproved uses of BOTOX®. The safety and effectiveness of BOTOX® for unapproved uses have not been established.
Serious and/or immediate hypersensitivity reactions have been reported. These reactions include anaphylaxis, serum sickness, urticaria, soft-tissue edema, and dyspnea. If such reactions occur, further injection of BOTOX® Cosmetic should be discontinued and appropriate medical therapy immediately instituted. One fatal case of anaphylaxis has been reported in which lidocaine was used as the diluent and, consequently, the causal agent cannot be reliably determined.
There have been reports following administration of BOTOX® of adverse events involving the cardiovascular system, including arrhythmia and myocardial infarction, some with fatal outcomes. Some of these patients had risk factors including pre-existing cardiovascular disease. Use caution when administering to patients with pre-existing cardiovascular disease.
Increased Risk of Clinically Significant Effects With Pre-existing Neuromuscular Disorders
Individuals with peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, or neuromuscular junction disorders (eg, myasthenia gravis or Lambert-Eaton syndrome) should be monitored when given botulinum toxin. Patients with neuromuscular disorders may be at increased risk of clinically significant effects including generalized muscle weakness, diplopia, ptosis, dysphonia, dysarthria, severe dysphagia, and respiratory compromise from onabotulinumtoxinA (see Warnings and Precautions).
Dysphagia and Breathing Difficulties
Treatment with BOTOX® and other botulinum toxin products can result in swallowing or breathing difficulties. Patients with pre-existing swallowing or breathing difficulties may be more susceptible to these complications. In most cases, this is a consequence of weakening of muscles in the area of injection that are involved in breathing or oropharyngeal muscles that control swallowing or breathing (see Boxed Warning).
Pre-existing Conditions at the Injection Site
Caution should be used when BOTOX® Cosmetic treatment is used in the presence of inflammation at the proposed injection site(s) or when excessive weakness or atrophy is present in the target muscle(s).
Dry Eye in Patients Treated With BOTOX® Cosmetic
There have been reports of dry eye associated with BOTOX® Cosmetic injection in or near the orbicularis oculi muscle. If symptoms of dry eye (eg, eye irritation, photophobia, or visual changes) persist, consider referring patients to an ophthalmologist.
Human Albumin and Transmission of Viral Diseases
This product contains albumin, a derivative of human blood. Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases and variant Creutzfeldt-Jakob disease (vCJD). There is a theoretical risk for transmission of Creutzfeldt-Jakob disease (CJD), but if that risk actually exists, the risk of transmission would also be considered extremely remote. No cases of transmission of viral diseases, CJD or vCJD have ever been identified for licensed albumin or albumin contained in other licensed products.
The most frequently reported adverse reactions following injection of BOTOX® Cosmetic for glabellar lines were eyelid ptosis (3%), facial pain (1%), facial paresis (1%), and muscular weakness (1%).
The most frequently reported adverse reaction following injection of BOTOX® Cosmetic for lateral canthal lines was eyelid edema (1%).
The most frequently reported adverse reactions following injection of BOTOX® Cosmetic for forehead lines with glabellar lines were headache (9%), brow ptosis (2%), and eyelid ptosis (2%).
Co-administration of BOTOX® Cosmetic and aminoglycosides or other agents interfering with neuromuscular transmission (eg, curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated. Use of anticholinergic drugs after administration of BOTOX® Cosmetic may potentiate systemic anticholinergic effects.
The effect of administering different botulinum neurotoxin products at the same time or within several months of each other is unknown. Excessive neuromuscular weakness may be exacerbated by administration of another botulinum toxin prior to the resolution of the effects of a previously administered botulinum toxin.
Excessive weakness may also be exaggerated by administration of a muscle relaxant before or after administration of BOTOX® Cosmetic.
USE IN SPECIFIC POPULATIONS There are no studies or adequate data from postmarketing surveillance on the developmental risk associated with use of BOTOX® Cosmetic in pregnant women. There are no data on the presence of BOTOX® Cosmetic in human or animal milk, the effects on the breastfed child, or the effects on milk production.
[Insert appropriate PI statement]